Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations.

Power, John R; Keyt, Lucas K; Adler, Eric D

Power, John R; Keyt, Lucas K; Adler, Eric D.

Afiliación

Power JR; Division of Cardiovascular Medicine, University of California San Diego, San Diego, California, United States.
Keyt LK; Division of Cardiovascular Medicine, University of California San Diego, San Diego, California, United States.
Adler ED; Division of Cardiovascular Medicine, University of California San Diego, San Diego, California, United States.

Expert Rev Cardiovasc Ther ; 20(4): 241-251, 2022 Apr.

Article en En | MEDLINE | ID: mdl-35414326

Asunto(s)

Vacunas contra la COVID-19; COVID-19; Miocarditis; Vacunación; COVID-19/prevención & control; Vacunas contra la COVID-19/efectos adversos; Humanos; Incidencia; Masculino; Miocarditis/inducido químicamente; SARS-CoV-2; Vacunación/efectos adversos

Palabras clave

COVID-19; Myocarditis; clinical; in vitro transcribed mRNA; incidence; innate immune system; molecular mimicry; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunación / Vacunas contra la COVID-19 / COVID-19 / Miocarditis Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Expert Rev Cardiovasc Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google